Science and Research

A Randomised, Double-blind, Multi-centre, Placebo-controlled, Crossover Study to Assess the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler on Cardiac and Lung Function in Participants with Chronic Obstructive Pulmonary Disease and Hyperinflation (ORATOS)

The effect of BGF relative to placebo on LVEDVi in participants with COPD and hyperinflation will be evaluated

Study details
Study-ID: 2025-521987-37-00
Study-ID: 2025-521987-37-00
DZL Disease Area: COPD
DZL Disease Area: COPD
Study Type: Interventional
Study Type: Interventional
DZL Role: DZL on steering board
DZL Role: DZL on steering board
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: ARCN, BREATH
DZL Participating Sites: ARCN, BREATH
Start Date: 24.11.2025
Completion Date: 31.12.2030
Status: Recruiting
Status: Recruiting
DZL on steering board
Link to Study


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.